1199.177.1067 Boehringer Ingelheim Investigational Site

Houston, Texas

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis

Studies at this site

• Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP) — APPROVED_FOR_MARKETING